GHA is pleased to announce that The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), located in Hangzhou, China, has received the GHA Certification of Excellence in International Medical Travel Patient Experience with the rank of Distinction. The honor acknowledges the hospital's impressive performance in delivering a coordinated, patient-centered experience for individuals seeking care across borders. SAHZU is the first hospital in China to receive this recognition.
Longevity programs collect rich patient data, but little is published. In this fourth article in her series, Renée-Marie Stephano, CEO of Global Healthcare Accreditation, argues the field will earn trust only by openly publishing all outcomes, including disappointing ones. She calls for measuring function over biomarkers, reporting results alongside social determinants of health, and committing to six principles for open, independent, comparable outcome reporting.
A four-part series by GHA CEO Renée-Marie Stephano on building credible longevity and regenerative medicine. The articles cover why healthspan should be the goal, how to connect prevention with clinical care, why the field needs an evidence-based standard, and how GHA plans to keep that standard honest through independent scientific advice, open expert review, and real-world outcome tracking.
CureMeAbroad Inc. has achieved GHA Medical Travel Facilitator Certification, becoming the first medical travel startup in India to achieve the certification with Global Healthcare Accreditation. With a global network of more than 400 accredited hospitals across six countries, CureMeAbroad is strengthening transparency, accountability, and patient-centered practices across the international patient journey.
Global Healthcare Accreditation and Emirates are working to extend patient-centered standards into air travel, advancing a more connected journey for international patients and new opportunities for healthcare providers.
Healthy longevity is expanding quickly, and clients increasingly struggle to distinguish credible medical programs from wellness offerings with limited evidence. This article highlights why the industry needs clear standards to ensure transparency, protect patients, and help organizations deliver truly evidence‑based longevity care.
Accreditation can transform how ahealthcare organization works. But can it influence a patient’s choice if thepatient never sees it? Healthcare organizations invest heavily in standards,safeguards, governance, and continuous improvement, yet the resulting qualitysignal may never reach the people it is intended to reassure. Findings fromGHA’s IMPACT™ Study suggest that this “last mile” cannot be taken for granted.